Gonadotropin-releasing hormone increases CD4+ T-lymphocyte numbers in an animal model of immunodeficiency

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 3 II, 1999, Pages 653-658

  Jacobson, Jill D ^a,d   Ansari, Mansoor A ^a   Mansfield, Matthew E ^b   McArthur, Carole P ^b   Clement, Loran T ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Autoimmunity; CD4+ T lymphocytes; Gonadotropin releasing hormone; Immunodeficiency; Immunoglobulins

Indexed keywords

CD4 ANTIGEN; GONADORELIN; IMMUNOGLOBULIN G; LUTEINIZING HORMONE;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; LEUKOCYTE COUNT; LUTEINIZING HORMONE BLOOD LEVEL; LYMPHOCYTOPENIA; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0032821795     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70338-6     Document Type: Article

References (34)

1. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Ann Rev Immunol 1995;13:307-38.
2. Marchetti B, Guarcello V, Morale MC, Bartoloni G, Raiti F, Palumbo G, et al. LHRH agonist restoration of age associated decline of thymus weight: thymic LHRH receptors and thymocyte proliferative capacity. Endocrinology 1989;125:1037-45.
3. Morale MC, Batticane N, Bartoloni G, Guarcello V, Farinella M, Galasso G, et al. Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH antagonist inhibits morphofunctional development of the thymus and maturation of the cell-mediated and humoral immune responses. Endocrinology 1991;128:1073-85.
4. Emanuele NV, Emanuele MA, Tentler J, Kirsteins L, Azad N, Lawrence AM. Rat spleen lymphocytes contain an immunoreactive and bioactive LHRH. Endocrinology 1990;126:2482-6.
5. Maier CC, Marchetti B, Leboeof RD, Blalock LE. Thymocytes express an mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA. Cell Mol Neurobiol 1992;12:447-54.
6. Azad N, La Paglia N, Jurgens AJ, Kirstens L, Emmanuele NV, Kelley MR, et al. Immunoactivation enhances the concentration of luteinizing hormone-releasing hormone peptide and its gene expression in human peripheral T-lymphocytes. Endocrinology 1993;133:215-23.
7. Jacobson JD, Nisula BC, Steinberg AD. Modulation of expression of murine lupus by gonadotropin-releasing hormone analogs. Endocrinology 1994;134:2516-23.
8. Elder ME, MacLaren NK. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J Immunol 1983;130:1723-31.
9. Like AA, Forster RM, Woda BA, Rossini AA. T-cell subsets in islets and lymph nodes of BioBreeding Worcester (BBAV) rats [abstract]. Diabetes 1983;32:51A.
10. Naji A, Silvers WK, Kimura H, Belgrau D, Markham JF, Barker CF. Analytical and functional studies on the T-cells of untreated and immunologically tolerant diabetes-prone BB rats. J Immunol 1983;130:2168-72.
11. Yale JF, Marliss EB. Altered immunity and diabetes in the BB rat. Clin Exp Immunol 1984;57:1-11.
12. Like AA, Guberski DL, Butler L. Diabetic Biobreeding/Worcestor (BB/Wor) rats need not be lymphopenic. J Immunol 1986;136:3254-8.
13. Scott J, Engelhard VH, Benjamin DC. Bone marrow irradiation chimeras in the BB rat: evidence suggesting two defects leading to diabetes and lymphopenia. Diabetologia 1987;30:774-81.
14. Niswender GD, Midfley AR, Monroe SE, Reichert LE. Radioimmunoassay for rat luteinizing hormone with anti-ovine LH serum and ovine LH. Proc Soc Exp Biol Med 1968;128:807-11.
15. Batticane N, Morale MC, Gallo F, Farinella Z, Marchetti B. Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. Endocrinology 1991;129:277-86.
16. Iwakoshi NN, Goldschneider I, Tausche F, Mordes JO, Rossini AA, Greiner DL. High frequency apoptosis of recent thymic emigrants in the liver of lymphopenic diabetes-prone BioBreeding rats. J Immunol 1998;160:5838-50.
17. Ramanatha S, Norwich K, Poussier P. Antigen activation rescues recent thymic emigrants from programmed cell death in the BB rat. J Immunol 1998;160:5757-64.
18. Blalock JE, Harbout-McMenamin D, Smith EM. Peptide hormones shared by the neuroendocrine and immunologic systems. J Immunol 1985;135:858-61s.
19. Deschaux P, Lenzi-Devaux G, Rouhabia M. Natural killer cells and cytotoxic T lymphocytes activities can be differentiated by their different sensitivities to pituitary hormones in vitro (LH, FSH, ACTH, GH). Boll Soc Ital Sper 1986;62:763-70.
20. Weesner GD, Becker BA, Matteri RL. Expression of luteinizing hormone-releasing hormone and its receptor in porcine immune tissues. Life Sci 1997;61:1643-9.
21. Chen H, Jeung E, Stephenson M, Leung PCK. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor g-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab 1999;84:743-50.
22. Jacobson JD, Crofford LJ, Sun L, Wilder RL. Cyclical expression of GnRH and GnRH receptor mRNA in lymphoid organs. Neuroendocrinology 1998;67:117-25.
23. Hawes BE, Marzen JE, Waters SB, Conn PM. Sodium fluoride provokes gonadotrope desensitization to gonadotropin-releasing hormone (GnRH) and gonadotrope sensitization to A23187: evidence for multiple G proteins in GnRH action. Endocrinology 1992;130:2465-75.
24. Hawes BE, Conn PM. Assessment of the role of G proteins and inositol phosphate production in the action of gonadotropin-releasing hormone. Clin Chem 1993;39:325-32.
25. Jacobson JD, Kinealy M, Muthukrishnan V, Ansari MA. Gender specific exacerbation of murine lupus by gonadotropin-releasing hormone: role of G aq/11. Endocrinology 1999. In press.
26. Yale JF, Grose M, Marliss EB. Time course of the lymphopenia in BB rats: relation to the onset of diabetes. Diabetes 1985;34:955-9.
27. Fraser GR. Goitre in Klinefelter's syndrome. BMJ 1963;1:1284.
28. William ED, Engel E, Forbes AP. Thyroiditis and gonadal agenesis. N Engl J Med 1964;270:805-10.
29. Belvisi L, Bombelli F, Sironi L, Doldi N. Organ-specific autoinimunity in patients with premature ovarian failure. J Endocrinol Invest 1993;16:889-92.
30. Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988;84:611-6.
31. Saravolatz L, Neaton JD, Sacks L, Deyton L, Rhame F, Sherer R. CD4+ T lymphocyte counts and patterns of mortality among patients infected with human immunodeficiency virus who were enrolled in community programs for clinical research on AIDS. Clin Infect Dis 1996;22:513-20.
32. McDougall B, Nymark MH, Landucci G, Forthal D, Robinson, WE. Predominance of detrimental humoral immune responses to HFV-1 in AIDS patients with CD4 lymphocyte counts less than 400/mm3. Scand J Immunol 1997;45:103-11.
33. Bagatelle CJ, McLachlan RI, de Kretser DM, Burger JG, Vale WW, Rivier JE. A comparison of the suppressive effects of testosterone and a potent new gonadotropin hormone-releasing hormone antagonist on gonadotropin and inhibin levels in normal men. J Clin Endocrinol Metab 1989;69:43-8.
34. Tenover JS, Dahl KD, Vale WW, Rivier JE, Bremner WJ. Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men. J Clin Endocrinol Metab 1990;71:881-8.